Delivery Order N0018914DE006-0009

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a for-profit medical device manufacturer, for $7,142.85. The contract is for the supply and rental of Regenesis' Provant Therapy System, a non-invasive regenerative medicine product, to VA medical facilities. The contract has an ultimate completion date of May 6, 2011 and was awarded on April 6, 2011. This purchase order was issued under Regenesis' existing General...

This federal contract award, valued at $4,820.98, was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The contract is for the provision of the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical, to VA medical facilities. The contract was awarded as a purchase order under Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A...

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company. The contract is for the provision of Regenesis Biomedical's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has a ceiling value of $7,231.47 and a completion date of June 24, 2011. There is no set-aside designation...

This is a federal contract award from the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company. The $7,055.10 firm-fixed-price purchase order is for the company's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has no set-aside designation and was awarded on December 16, 2010, with a completion date of January 16, 2011. Regenesis Biomedical, the...

This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The contract does not utilize any set-aside designations. Based on the information provided, Regenesis Biomedical acts as the prime contractor and does not subcontract...

This federal contract award is for WOUND CARE products and services provided by Regenesis Biomedical Inc., a privately held medical technology company, to the U.S. Department of Veterans Affairs (VA). The contract, valued at $7,851.06, was awarded on December 22, 2011 and has a firm fixed price. The contract is not set aside for any preferential contracting vehicle. Regenesis Biomedical's primary offering under this contract is the Provant Therapy System, a patented regenerative medicine product...

This federal contract award is for the purchase of the Provant Therapy System, a non-invasive regenerative medicine product developed and provided by Regenesis Biomedical Inc., a privately held medical technology company. The contract, valued at $3,645.14, was awarded by the Department of Veterans Affairs (VA) and is for the delivery of the Provant Therapy System to the VA's Integrated Service Network 17, which covers several states. The contract does not have a set-aside designation, and...

The Department of Commerce National Institute of Standards and Technology (NIST) awarded a $2,214,773.00 Firm Fixed Price Purchase Order to the Standards Coordinating Body For Gene Cell & Regenerative Medicines, a Non-Profit Organization, for the development of STANDARDS DEVELOPMENT FOR REGENERATIVE MEDICINE THERAPIES. The contract has a completion date of May 2, 2026 and does not utilize a set-aside designation. This work supports NIST's role in developing standards and measurement tools to...

The Department of the Navy Naval Sea Systems Command (DOD - Navy) awarded a $556,670 firm fixed price delivery order contract to Evoqua Water Technologies LLC, doing business as Usfilter Corp, to provide regeneration services. The contract has a period of performance from April 5, 2022 to April 5, 2023 and will be performed in Portsmouth, Virginia. Evoqua Water Technologies LLC will utilize regeneration to treat and recycle used materials for the Navy, helping to support fleet operations from...

This is a purchase order contract awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a for-profit medical technology company, for the provision of the Provant Therapy System. The Provant Therapy System is a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has a ceiling value of $4,882.79 and is a firm fixed-price arrangement. It was awarded on January 27, 2011, with a planned...